JEFFREY B. KINDLER

Insider Reports History

Location
Allegan, MI
Signature
/s/ David Strauss, as Attorney-in-Fact for Jeffrey B Kindler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JEFFREY B. KINDLER:

Company Role Class Num Shares Value Price $ Report Date Ownership
PRECIGEN, INC. Director Common Stock 110,603 $402,030 $3.63 12 Dec 2025 Direct
PERRIGO Co plc Director Ordinary Shares 10,559 $274,639 $26.01 14 May 2025 Direct
PRECIGEN, INC. Director Restricted Stock Units 0 $0 $1.74 14 Mar 2025 Direct
PRECIGEN, INC. Director Option to Purchase Common Stock (Right to Buy) 83,517 13 Mar 2025 Direct
Terns Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 1,697 01 Feb 2026 Direct
PERRIGO Co plc Director Restricted Stock Units 0 14 May 2025 Direct
PPD, Inc. Director Common Stock 0 $47.50 08 Dec 2021 By Trust
PPD, Inc. Director Common Stock 0 $47.50 08 Dec 2021 Direct

Insider Reports Filed by JEFFREY B. KINDLER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TERN Terns Pharmaceuticals, Inc. 01 Feb 2026 1 $0 4 Director 02 Feb 2026, 18:05
PRAX Praxis Precision Medicines, Inc. 08 Jan 2026 0 $0 3 Director 12 Jan 2026, 17:44
PGEN PRECIGEN, INC. 12 Dec 2025 1 -$855,899 4 Director 16 Dec 2025, 16:16
PGEN PRECIGEN, INC. 29 Sep 2025 2 -$604,192 4 Director 01 Oct 2025, 17:16
TERN Terns Pharmaceuticals, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 17:43
PRGO PERRIGO Co plc 14 May 2025 4 +$133,952 4 Director 16 May 2025, 11:52
PGEN PRECIGEN, INC. 13 Mar 2025 5 +$69,000 4 Director 17 Mar 2025, 18:30
TERN Terns Pharmaceuticals, Inc. 01 Feb 2025 1 $0 4 Director 03 Feb 2025, 19:31
PRGO PERRIGO Co plc 09 Dec 2024 1 -$497,495 4 Director 10 Dec 2024, 10:45
TERN Terns Pharmaceuticals, Inc. 01 Jul 2024 1 $0 4 Director 02 Jul 2024, 18:36
TERN Terns Pharmaceuticals, Inc. 10 Jun 2024 1 $0 4 Director 14 Jun 2024, 18:04
PRGO PERRIGO Co plc 14 May 2024 4 +$137,713 4 Director 16 May 2024, 19:26
PGEN PRECIGEN, INC. 14 Mar 2024 3 +$68,999 4 Director 18 Mar 2024, 18:16
PGEN PRECIGEN, INC. 09 Mar 2024 2 $0 4 Director 12 Mar 2024, 19:50
PGEN PRECIGEN, INC. 28 Dec 2023 1 -$136,327 4 Director 29 Dec 2023, 19:19
TERN Terns Pharmaceuticals, Inc. 12 Jun 2023 1 $0 4 Director 14 Jun 2023, 19:01
PRGO PERRIGO Co plc 17 May 2023 3 +$132,886 4 Director 19 May 2023, 14:39
PRGO PERRIGO Co plc 15 May 2023 1 $0 4 Director 17 May 2023, 15:40
PGEN PRECIGEN, INC. 09 Mar 2023 3 +$69,000 4 Director 13 Mar 2023, 17:04
PGEN PRECIGEN, INC. 22 Feb 2023 2 $0 4 Director 24 Feb 2023, 19:12
PGEN PRECIGEN, INC. 11 Aug 2022 1 -$115,000 4 Director 15 Aug 2022, 18:28
TERN Terns Pharmaceuticals, Inc. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 21:00
PRGO PERRIGO Co plc 17 May 2022 4 +$132,334 4 Director 19 May 2022, 13:52
PGEN PRECIGEN, INC. 25 Mar 2022 2 $0 4 Director 29 Mar 2022, 17:07
PGEN PRECIGEN, INC. 22 Feb 2022 3 +$69,000 4 Director 24 Feb 2022, 16:44
/report/000143774921028111-kindler-jeffrey-b-2021-12-08 PPD, Inc. 08 Dec 2021 2 -$5,604,382 4 Director 08 Dec 2021, 15:39
TERN Terns Pharmaceuticals, Inc. 28 Sep 2021 1 $0 4 Director 30 Sep 2021, 21:17
PRGO PERRIGO Co plc 17 May 2021 1 $0 4 Director 19 May 2021, 12:59
PRGO PERRIGO Co plc 07 May 2021 3 +$129,653 4 Director 11 May 2021, 14:57